72.62 USD
↗ 0.66 (0.92%)AT CLOSE (11:59 AM EDT)
GRAIL, Inc. Common Stock
GRALNASDAQ • USD
71.52
↘ 1.10 (1.51%)
POST MARKET (AS OF 06:50 PM EDT)
Post Market
AS OF 06:50 PM EDT
71.52
↘ 1.10 (1.51%)
Market: CLOSED
GRAIL, Inc. Common Stock (GRAL) trades at $72.62 per share. GRAL shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place GRAL at a fair price relative to peers.
Technical & fundamental data as of Jul 17, 2026.
Open?$70.00
High?$72.75
Low?$69.69
Prev. Close?$71.96
Volume?413.8K
Avg. Volume?619.6K
VWAP?$71.77
Rel. Volume?0.67x
Bid / Ask
Bid?$68.00 × 100
Ask?$72.99 × 500
Spread?$4.99
Midpoint?$70.50
Valuation & Ratios
Market Cap?3.1B
Shares Out?42.9M
Float?34.8M
Float %?89.3%
P/E Ratio?N/A
P/B Ratio?1.25
EPS?-$9.21
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Address
1525 O'BRIEN DRIVE
MENLO PARK, CA 94025
Phone: (833) 694-2553
MENLO PARK, CA 94025
Phone: (833) 694-2553
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?97
Short Sent.?14
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.70Distress
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?22.26%Squeeze Risk
Short Interest?7.8M
Days to Cover?11.1
Free Float34.8M
Avg Daily Volume698.3K
Settlement Date2026-06-30
Financial Health
Current Ratio?11.74Strong
Quick Ratio?11.51Strong
Cash Ratio?0.93Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.25CHEAP▾
Peers100
S&P92
P/S?19.96HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-8.5CHEAP▾
S&P97
EV/Sales?19.52HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-15.8%WEAK▾
S&P8
ROA?-14.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-292334000
Enterprise Value?$3.0B
Fundamentals ratios updated end of day